Functional analysis of the CD+ T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression

Journal of Virology

Volumn 74, Issue 14, 2000, Pages 6675-6679

  Fu, Zheng ^a,b   Cannon, Martin J ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 39; ANTIVIRUS AGENT; BREFELDIN A; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; CD40 ANTIGEN; CD40 LIGAND; DNA BINDING PROTEIN; MEMBRANE PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL; VIRUS EXPRESSION; CD4+ T LYMPHOCYTE; HELPER CELL; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; VIRUS ACTIVATION; VIRUS LATENCY;

ANTIGENS, CD40; ANTIVIRAL AGENTS; B-LYMPHOCYTES; BREFELDIN A; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CYTOKINES; DNA-BINDING PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE GLYCOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS; TRANS-ACTIVATORS; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0033625505     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.14.6675-6679.2000     Document Type: Article

References (24)

1. Banchereau, J., P. de Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70-72.
2. Boyle, T. J., R. E. Coles, A. M. Kizilbash, and H. K. Lyerly. 1992. Effects of cyclosporine on human B-cell lymphoma development in vivo. Surg. Oncol. 1:79-86.
3. Chen, F., J.-Z. Zou, L. di Renzo, G. Winberg, L.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:3752-3758.
4. Cocks, B. G., R. de Waal Malefyt, J.-P. Galizzi, J. E. de Vries, and G. Aversa. 1993. IL-13 induces proliferation and differentiation of human B cells activated bv the CD40 ligand. Int. Immunol. 5:657-663.
5. Coles, R. E., T. J. Boyle, J. M. DiMaio, K. R. Berend, D. F. Via, and H. K. Lyerly. 1994. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice. Ann. Surg. Oncol. 1:405-410.
6. Davies, A. H., R. J. Grand, F. J. Evans, and A. B. Rickinson. 1991. Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C. J. Virol. 65:6838-6844.
7. De Vries, J. E. 1996. Molecular and biological characteristics of interleukin-13. Chem. Immunol. 63:204-218.
8. Faris, M., F. Gaskin, J. T. Parsons, and S. M. Fu. 1994. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp. Med. 179:1923-1931.
9. Khanna, R., S. R. Burrows, and D. J. Moss. 1995. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59:387-405.
10. Martinez, O. M., J. C. Villanueva, L. Lawrence-Miyasaki, M. B. Quinn, K. Cox, and S. M. Krams. 1995. Viral and immunologic aspects of EBV infection in pediatric liver transplant patients. Transplantation 59:519-524.
11. Mathur, A., D. M. Kamat, A. H. Filipovich, M. Steinbuch, and R. S. Shapiro. 1994. Immunoregulatory abnormalities in patients with EBV-associated B cell lymphoproliferative disorders. Transplantation 57:1042-1045.
12. Misko, I. S., D. J. Moss, and J. H. Pope. 1980. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 77:4247-4250.
13. Misko, I. S., J. H. Pope, R. Hutter, T. D. Soszynski, and R. G. Kane. 1984. HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell colonies. Int. J. Cancer 33:239-243.
14. + cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Cell. Immunol. 132:295-307.
15. + T cell response to Epstein-Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders. Blood 91:3875-3883.
16. Prang, N. S., M. W. Hornef, M. Jager, H. J. Wagner, H. Wolf, and F. M. Schwarzmann. 1997. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89:1665-1677.
17. + cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice. Transplantation 58:629-633.
18. Rickinson, A. B., M. Rowe, I. J. Hart, Q. Y. Yao, L. E. Henderson, H. Rabin, and M. A. Epstein. 1984. T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cell. Immunol. 87:646-658.
19. Rickinson, A. B., S. P. Lee, and N. M. Steven. 1996. Cytotoxic T lymphocyte responses to Epstein-Barr virus. Curr. Opin. Immunol. 8:492-497.
20. Riddler, S. A., M. C. Breinig, and J. L. McKnight. 1994. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antihody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972-984.
21. Sample, J., M. Hummel, D. Braun, M. Birkenbach, and E. Kieff. 1986. Nucleotide sequence of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcription initiation site. Proc. Natl. Acad. Sci. USA 83:5096-5100.
22. Veronese, M. L., A. Veronesi, E. D'Andrea, A. Del Mistro, S. Indraccolo, M. R. Mazza, M. Mion, R. Zamarchi, C. Menin, M. Panozzo, A. Amadori, and L. Chieco-Bianchi. 1992. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J. Exp. Med. 176:1763-1767.
23. + T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis. Int. Immunol. 10:1149-1157.
24. Yao, Q. Y., H. Czarnecka, and A. B. Rickinson. 1991. Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities. Int. J. Cancer 48:253-257.